Catheter Ablation versus Medical Rate Control in Atrial Fibrillation with Left Ventricular Systolic Dysfunction and Myocardial Fibrosis - The CAMERA-MRI II Randomized Trial

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Associate Professor Sandeep Prabhu

The Alfred Hospital, Melbourne (Australia)

4 More presentations in this session

Presentation thumbnail

Strain sUrveillance during Chemotherapy for improving Cardiovascular Outcomes: Results of a Randomized Trial of Cardioprotection for Reduced Myocardial Strain (SUCCOUR-MRI)

Professor T. Marwick (Melbourne, AU)

Presentation thumbnail

Sacubitril/valsartan compared to valsartan in regressing myocardial fibrosis in stage B heart failure: the REVERSE-LVH Trial

Doctor C. Chin (Singapore, SG)

Presentation thumbnail

Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction

Doctor J. Carberry (Glasgow, GB)

Presentation thumbnail

Sacubitril/valsartan in primary prevention of cancer-therapy related cardiac dysfunction in breast cancer patients.

Doctor Y. Hsu (Tainan, TW)

Access the full session

Session thumbnail

Smaller trials: cardiac function and remodelling

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources